Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Philippe Bonin"'
Autor:
Elise Paven, Clarisse Eveno, Philippe Bonin, Mohamed Bouattour, Sandrine Faivre, Eric Raymond, Matthieu Martinet, Annemilaï Tijeras-Raballand, Marc Pocard, Armand de Gramont, C. Hobeika
Publikováno v:
Molecular Cancer Therapeutics. 17:B145-B145
Introduction: Galunisertib, a selective ATP-mimetic TGF-β receptor (TGFβR)-I inhibitor, displays a very safe toxicity profile in clinical trials, making it suitable for combinations. Galunisertib showed activity as second-line treatment in advanced
Autor:
C. Hobeika, Clarisse Eveno, Sandrine Faivre, Eric Raymond, Mohamed Bouattour, Annemilaï Tijeras-Raballand, Matthieu Martinet, Philippe Bonin, Marc Pocard, Armand de Gramont, Elise Paven
Publikováno v:
Molecular Cancer Therapeutics. 17:B144-B144
Introduction: Notch pathway has been involved in cell fate determination, cell differentiation, proliferation, and death. Notch promotes cell survival, angiogenesis, and treatment resistance in numerous cancers, making it a promising target for cance
Autor:
Pierre-Yves Le Pennec, Philippe Rouger, Carine Auxerre, Geneviève Juszczak, Thierry Peyrard, Bach-Nga Pham, Sandrine Godin, Philippe Bonin
Publikováno v:
Transfusion. 49:1329-1334
BACKGROUND: In the Rh blood group system, published observations showed that the c antigen has the fewest variant forms of the principal antigens in this system. The partial nature of the c antigen was only reported in c+ Rh:−26 persons and to be a
Autor:
Philippe Chadebech, Anoosha Habibi, Ruben Nzouakou, Dora Bachir, Natacha Meunier-Costes, Philippe Bonin, Martine Rodet, Btissam Chami, Frederic Galacteros, Philippe Bierling, France Noizat-Pirenne
Publikováno v:
Transfusion. 49:1785-1792
BACKGROUND: Delayed hemolytic transfusion reaction (DHTR) is a life-threatening complication in sickle cell disease (SCD) characterized by recurrence of disease complications, recipient red blood cell (RBC) destruction, and frequently no detectable a
Autor:
Frédéric Galactéros, Philippe Bonin, Martine Rodet, Philippe Bierling, K. Lee, Dora Bachir, Btissam Chami, Philippe Chadebech, F. Noizat-Pirenne, Anoosha Habibi, N. Meunier
Publikováno v:
Transfusion Clinique et Biologique
Transfusion Clinique et Biologique, Elsevier, 2008, 15 (6), pp.377-382. ⟨10.1016/j.tracli.2008.10.002⟩
Transfusion Clinique et Biologique, Elsevier, 2008, 15 (6), pp.377-382. ⟨10.1016/j.tracli.2008.10.002⟩
Background: Prevention of hemolytic transfusion reactions depends upon our capacity to prevent allo-immunization and conflicts between antigens of transfused red blood cells and antibodies produced by the recipient. In this study, we show that to sec
Autor:
France Noizat-Pirenne, Martine Verdier, Annette Lejealle, Anne Mercadier, Philippe Bonin, Françoise Peltier-Pujol, Anne Fialaire-Legendre, Christophe Tournamille, Philippe Bierling, Hélène Ansart-Pirenne
Publikováno v:
Transfusion. 47:1616-1620
BACKGROUND: Weak D Types 1, 2, and 3 recipients cannot be immunized when exposed to D antigen. Molecular biology is very efficient to type weak D variants but rarely implemented in daily practice. The serologic typing practice of weak D in a Caucasia
Publikováno v:
Journal of Endodontics. 24:359-363
Nd:YAP laser is a dental laser with a 1340 nm wavelength. The laser beam is carried by a 200 to 300 microns fiberoptic and is suitable for endodontic therapy. We used the Nd:YAP laser in an in vitro experiment to study its effectiveness in endodontic
Autor:
Dominique Desvaux-Belghiti, H Terzidis, Claude Philippon, Gilbert Lagrue, M Petit-Phar, Bertrand Weil, Philippe Bierling, Liliane Intrator, Serge Adnot, Philippe Remy, Guy Rostoker, Philippe Lang, Philippe Bonin, Deforges L, Chantal Andre, Yannick Pilatte
Publikováno v:
Nephron. 69:327-334
Recently, our group has shown that a 3-month course of intravenous immunoglobulin (2 g/kg/monthly) followed by 6 months of intramuscular immunoglobulins (IMIG, 16.5%, 0.35 ml/kg every 15 days) was abl
Autor:
Frédéric Galactéros, F. Beaujean, J. Nadjahi, Najib Duedari, Dora Bachir, Françoise Norol, Philippe Bierling, Philippe Bonin, C. Desaint, M. Guillou Bataille
Publikováno v:
Transfusion Clinique et Biologique. 1:27-34
Transfusion therapy for sickle cell anemia is limited by the development of antibodies to red cell antigens. The aim of this study was to evaluate whether transfusion of blood matched for antigens Rh and Kell would reduce the incidence of alloimmuniz
Autor:
Stéphanie Martin-Blanc, Bach-Nga Pham, Pierre-Yves Le Pennec, Sandrine Kappler-Gratias, Philippe Bonin, Thierry Peyrard, Carine Auxerre, Sylvie Poupel, Philippe Rouger
Publikováno v:
Transfusion. 49(11)
BACKGROUND:ceAR (RHCE*ceAR) is a rare RH allele encountered in people of African/Caribbean ancestry, known to encode a partial e antigen. The homozygous ceAR/ceAR genotype encodes the rare blood group Hr−. This study describes alloanti-c/ce in a ce